ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 395

$567K Total Retail Price of All Prescriptions

Rank: 62 out of 395

345 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 345 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 345 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 357 234 18 1 19
AMLODIPINE BESYLATE 293 259 56 2 4
PRAVASTATIN SODIUM 253 234 62 3 16
LEVOTHYROXINE SODIUM 248 219 43 4 3
OMEPRAZOLE 232 190 44 5 6
LISINOPRIL 216 211* 37 6 1
FUROSEMIDE 209 197 33 7 10
DONEPEZIL HCL 200 200 28 8 36
NAMENDA 190 190 21 9 45
TRAZODONE HCL 182 155 44 10 41
POTASSIUM CHLORIDE 173 153 35 11 22
ATORVASTATIN CALCIUM 171 136 40 12 8
METOPROLOL TARTRATE 160 141 27 13 11
METFORMIN HCL 155 139 35 14 7
SERTRALINE HCL 145 127 33 15 31
SIMVASTATIN 143 127 33 16 2
TEMAZEPAM 139 <11 <11 B 17 33
ALENDRONATE SODIUM 127 122* 12 18 20
BENAZEPRIL HCL 124 119* 32 19 52
HYDROCODONE-ACETAMINOPHEN 119 108 30 S3 20 5
RAMIPRIL 107 94 30 21 112
TAMSULOSIN HCL 107 102* 25 21 24
LORAZEPAM 102 97* 12 B 23 43
CLOPIDOGREL 101 96* 21 24 21
GLIPIZIDE 92 <11 <11 25 32
GABAPENTIN 91 63 16 26 12
METOPROLOL SUCCINATE 90 90 21 27 25
DIVALPROEX SODIUM 83 <11 <11 28 107
CITALOPRAM HBR 77 72* 14 29 26
LOSARTAN POTASSIUM 77 77 12 29 9
FINASTERIDE 76 <11 <11 31 58
OXYCODONE HCL-ACETAMINOPHEN 72 <11 <11 S2 32 48
ADVAIR DISKUS 71 59 15 33 50
ATENOLOL 71 71 16 33 15
ABILIFY 68 <11 <11 A 35 168
EXELON 65 <11 <11 36 165
INSULIN SYRINGE* 65 <11 <11 36 190
PANTOPRAZOLE SODIUM 64 64 16 38 35
CARVEDILOL 61 61 14 39 23
QUETIAPINE FUMARATE 61 <11 <11 A 39 79
CIPROFLOXACIN HCL 60 55* 30 41 54
JANUVIA 59 59 11 42 90
HALOPERIDOL 53 53 13 A 43 309
FLUTICASONE PROPIONATE 53 34 16 43 28
SPIRONOLACTONE 51 <11 <11 45 76
MONTELUKAST SODIUM 50 25 11 46 71
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.